Login / Signup

Autoimmune gastrointestinal dysmotility following SARS-CoV-2 infection successfully treated with intravenous immunoglobulin.

Mayra MontalvoPadmini NallapaneniSara HassanSamuel NurkoSean J PittockJulie Khlevner
Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)
This is the first report of AGID occurring after SARS-CoV-2 infection. The dramatic response to IVIG emphasizes the importance of early recognition and the reversible and treatable nature of this condition.
Keyphrases
  • respiratory syndrome coronavirus
  • multiple sclerosis
  • high dose
  • sars cov
  • coronavirus disease
  • low dose